today announced that its Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) clinical trial has commenced enrollment, with the first patient treated by Dr. Joseph Cardenas at Yuma ...

The Magic Touch PTA Sirolimus Coated Balloon Catheter is indicated for the treatment of Below the Knee (BTK) atherosclerotic lesions in Peripheral Arterial Disease. CMI received their first IDE ...

Disclaimer: The following press release comes to you under an arrangement with PR Newswire. takes no editorial responsibility for the same.) SINGAPORE, Aug. 27, 2020 /PRNewswire/ -- Concept ...

today announced the latest results from the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial, demonstrating that the Philips endovascular system – Tack (4F ...

First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease Follows Breakthrough Device designation for Virtue ...

MIAMI BEACH, FLA.—In patients with critical limb ischemia or life-limiting claudication, use of a drug-eluting balloon to treat below-the-knee arterial lesions is safe, feasible and produces favorable ...

WAYNE, Pa., Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that positive six-month results from its Tack Optimized Balloon ...

today announced the launch of the IN.PACT BTK study to evaluate the effectiveness of using a drug-coated balloon (DCB) in patients with below-the-knee (BTK) peripheral arterial disease (PAD).

SINGAPORE, Aug. 27, 2020 /PRNewswire/ -- Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the FUTURE BTK trial ...

Philips announces positive three-year clinical research results from its Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial GlobeNewswire June 13, 2022 For below-the ...